Close
Smartlab Europe
Achema middle east

Abbott India Confirms Drugs Are Fake And Not Their Make

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

AstraZeneca-Modella AI Acquisition to Speed Oncology R&D

AstraZeneca has agreed to acquire Boston-based Modella AI as...

Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience

Novartis has entered into a licensing agreement with SciNeuro...

Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach

In order to broaden its portfolio in imaging and...
- Advertisement -

Abbott informed yesterday, July 3rd, that there are several ways to tell if a customer’s pack of Thyronorm is authentic or fake. The label of the product has a QR code that, when scanned, opens a homepage with a video demonstrating the advantages of the flip-top pack. On the cap, a real Abbott emblem attests to the legitimacy of the pack, the company added.

This comes after questions concerning the genuinity of its drug Thyronorm were raised across the Indian state of Telengana. The pharma giant said that not only in Telangana, but pharmacies all over India continue to carry authentic and premium Thyronorm. They will keep working to warn authorities about counterfeiters for the protection and welfare of their patients.

The company confirmed that Thyronorm batches listed by Telangana’s Drugs Control Administration (DCA) as not meeting quality standards were neither produced nor distributed by the manufacturer and are therefore fakes. It also claimed to have informed the authorities about the availability of fake products on the market. A business representative confirmed that the batches of Thyronorm listed on the drugs control administration (DCA) government of Telangana list were undoubtedly fake and neither produced nor distributed by Abbott. The integrity of genuine Abbott products remains unaffected. In this instance, they contacted authorities preemptively about these potentially fake medications, and appropriate measures have been taken.

Latest stories

Related stories

AstraZeneca-Modella AI Acquisition to Speed Oncology R&D

AstraZeneca has agreed to acquire Boston-based Modella AI as...

Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience

Novartis has entered into a licensing agreement with SciNeuro...

Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach

In order to broaden its portfolio in imaging and...

UK Clinical Trial Regulatory Reforms Aim to Boost Research

A number of regulatory changes have been released by...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »